Anna A. Avagyan: Presenting Armenia’s Experience at SIOP Europe 2026
Anna A. Avagyan, Pediatric Hematologist/Oncologist at Pediatric Cancer and Blood Disorders Center of Armenia, shared a post on LinkedIn:
”SIOP Europe 2026 was a great mix of strong science and real-world clinical discussion – the kind of meeting where you come back with new ideas, better questions, and renewed energy from the people around you.
This year, I presented a clinical case from our center in Armenia in the Young SIOP session on childhood cancer predisposition syndromes.
I shared our experience with therapeutic decision-making in a child with an underlying genetic predisposition and significant treatment vulnerability-highlighting how ‘host biology’ can redefine what is feasible and safe when standard pathways are limited.
SIOP-E was also a great chance to reconnect with the network and to meet new colleagues and friends.
Thank you to everyone involved in this patient’s care and to the wider community advancing pediatric oncology through collaboration and shared learning.
Special thanks to the H. Hovnanian Family Foundation Armenia for supporting my participation at SIOP Europe.”

Stay updated with Hemostasis Today.
-
Jun 8, 2026, 03:05Shamsunisha Yusuff: Iron Down, Platelets Up in a Young CBC ?
-
Jun 8, 2026, 03:03Samwel Mikaye: D-Dimer – A Marker of Blood Clot Breakdown
-
Jun 8, 2026, 02:59Vinita Madhuri: Our Engagement, A Lifeline for Thalassemia Patients
-
Jun 7, 2026, 22:11Lucia Härtel: Exercise, IL-10 Signaling, and Post-Stroke Brain Plasticity
-
Jun 7, 2026, 19:35Ashish Pemawat: Is the 4.5-Hour Thrombolysis Window Becoming Less Relevant?
-
Jun 7, 2026, 18:25Nita Radhakrishnan: Every Child Cured Is a Reminder of What Can Be Achieved When We Work Together
-
Jun 7, 2026, 18:24Yvette Fairfax: Wiskott-Aldrich Gene Therapy Changes Immunity, but Affordability May Determine Survival
-
Jun 7, 2026, 18:21Gulab Makwana: Complete Guide to Clotting Factors – Understanding the Coagulation System
-
Jun 7, 2026, 18:15Chuhan Dong: Presenting My Research on Antibody-Mediated RBC Clearance at Canadian Blood Services